Teva Pharmaceuticals (31 Generic Drug Products) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Teva Pharmaceuticals (31 Generic Drug Products) General Information

Description

A portfolio of 31 generic drug products. The portfolio is comprised of 20 solid-oral, immediate-release products, four extended-release products and seven liquid products.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Israel
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
ANI Pharmaceuticals
Corporate Office
  • Israel

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Teva Pharmaceuticals (31 Generic Drug Products) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Teva Pharmaceuticals (31 Generic Drug Products)‘s full profile, request access.

Request a free trial

Teva Pharmaceuticals (31 Generic Drug Products) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Teva Pharmaceuticals (31 Generic Drug Products)‘s full profile, request access.

Request a free trial

Teva Pharmaceuticals (31 Generic Drug Products) FAQs

  • Where is Teva Pharmaceuticals (31 Generic Drug Products) headquartered?

    Teva Pharmaceuticals (31 Generic Drug Products) is headquartered in Israel.

  • What industry is Teva Pharmaceuticals (31 Generic Drug Products) in?

    Teva Pharmaceuticals (31 Generic Drug Products)’s primary industry is Buildings and Property.

  • Is Teva Pharmaceuticals (31 Generic Drug Products) a private or public company?

    Teva Pharmaceuticals (31 Generic Drug Products) is a Private company.

  • What is the current valuation of Teva Pharmaceuticals (31 Generic Drug Products)?

    The current valuation of Teva Pharmaceuticals (31 Generic Drug Products) is .

  • What is Teva Pharmaceuticals (31 Generic Drug Products)’s current revenue?

    The current revenue for Teva Pharmaceuticals (31 Generic Drug Products) is .

  • Who are Teva Pharmaceuticals (31 Generic Drug Products)’s investors?

    Teva Pharmaceutical Industries has invested in Teva Pharmaceuticals (31 Generic Drug Products).

  • When was Teva Pharmaceuticals (31 Generic Drug Products) acquired?

    Teva Pharmaceuticals (31 Generic Drug Products) was acquired on 26-Dec-2013.

  • Who acquired Teva Pharmaceuticals (31 Generic Drug Products)?

    Teva Pharmaceuticals (31 Generic Drug Products) was acquired by ANI Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »